Let’s try to improve the ups and downs of ITP

ITP myOpportunITy
myOpportunITy is comprised of three clinical studies that are evaluating a potential new subcutaneous (under the skin) infusion called rozanolixizumab for adults living with immune thrombocytopenia (ITP).
myOpportunITy currently enrolling

We’re looking for people to join the studies—and help us try to improve the ups and downs of ITP.
Would you or someone you care about consider taking part?

Find a
study site

myOpportunITy will be conducted at study sites around the world.